Korean Drugmakers at a Crossroads

Many experts say that coupled with the government’s plan to slash insurance drug prices, the country's medicine business is standing at a crossroads as the free trade pact between Korea and the United States takes effect from today; Is it going take a leap with new, innovative drugs or continue chasing global leaders with me-too products?

They should pursue the knowledge-intensive industry b...